Ngā hua rapu - Imre Noth

Whakamahine hua
  1. 1
    Peripheral blood biomarkers in idiopathic pulmonary fibrosis

    Peripheral blood biomarkers in idiopathic pulmonary fibrosis mā Rekha Vij, Imre Noth

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Idiopathic pulmonary fibrosis: Early detection and referral

    Idiopathic pulmonary fibrosis: Early detection and referral mā Justin M. Oldham, Imre Noth

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease

    Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease mā Ayodeji Adegunsoye, Rekha Vij, Imre Noth

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Autoimmune-Featured Interstitial Lung Disease

    Autoimmune-Featured Interstitial Lung Disease mā Rekha Vij, Imre Noth, Mary E. Strek

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A Variant in the Promoter of<i>MUC5B</i>and Idiopathic Pulmonary Fibrosis

    A Variant in the Promoter of<i>MUC5B</i>and Idiopathic Pulmonary Fibrosis mā Yingze Zhang, Imre Noth, Joe G. N. Garcia, Naftali Kaminski

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes

    Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes mā Rongrong Wei, Chong Li, Min Zhang, Yava Jones‐Hall, Jamie L. Myers, Imre Noth, Wanqing Liu

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis

    Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis mā Justin M. Oldham, Disha Kumar, Cathryn Lee, Shruti Patel, Stephenie Takahashi-Manns, Carley Demchuk, Mary E. Strek, Imre Noth

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials

    Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials mā Joyce Lee, Harold R. Collard, Kevin J. Anstrom, Fernando J. Martínez, Imre Noth, Rhonda Roberts, Eric Yow, Ganesh Raghu

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography

    Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography mā Justin M. Oldham, Ayodeji Adegunsoye, Satinderpal Singh Khera, Elyse LaFond, Imre Noth, Mary E. Strek, Michel Kadoch, Jonathan H. Chung

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis

    A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis mā Imre Noth, Kevin J. Anstrom, Sara B. Calvert, João A. de Andrade, Kevin Flaherty, Craig S. Glazer, Robert J. Kaner, Mitchell A. Olman

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis

    Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis mā David Zhang, Chad A. Newton, Binhan Wang, Gundula Povysil, Imre Noth, Fernando J. Martínez, Ganesh Raghu, David B. Goldstein, Christine Kim Garcia

    I whakaputaina 2022
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis

    The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis mā Jeffrey J. Swigris, MeiLan K. Han, Rekha Vij, Imre Noth, Eric L. Eisenstein, Kevin J. Anstrom, Kevin K. Brown, Diane L. Fairclough

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis

    Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis mā David S. Wilkes, Terrence Chew, Kevin R. Flaherty, Sarah Frye, Kevin F. Gibson, Naftali Kaminski, Michael J. Klemsz, Wade Lange, Imre Noth, Katia Rothhaar

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis

    Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis mā Chad A. Newton, David Zhang, Justin M. Oldham, Julia Kozlitina, Shwu‐Fan Ma, Fernando J. Martínez, Ganesh Raghu, Imre Noth, Christine Kim Garcia

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases

    Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases mā Ayodeji Adegunsoye, Justin M. Oldham, Shashi Bellam, Steven M. Montner, Matthew M. Churpek, Imre Noth, Rekha Vij, Mary E. Strek, Jonathan H. Chung

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis

    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis mā Michael Kreuter, David J. Lederer, María Molina‐Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis

    Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis mā Imre Noth, Steven Zangan, Renato Soares, Anne Forsythe, Carley Demchuk, Shinichiro Takahashi, Shruti Patel, Mary E. Strek, Jerry A. Krishnan, Marco G. Patti, Heber MacMahon

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features

    CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features mā Jonathan H. Chung, Steven M. Montner, Ayodeji Adegunsoye, Cathryn Lee, Justin M. Oldham, Aliya N. Husain, Heber MacMahon, Imre Noth, Rekha Vij, Mary E. Strek

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease

    Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease mā Shehabaldin Alqalyoobi, Ayodeji Adegunsoye, A. Linderholm, Cara L. Hrusch, Claire C. Cutting, Shwu‐Fan Ma, Anne I. Sperling, Imre Noth, Mary E. Strek, Justin M. Oldham

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Carta
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis

    PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis mā Yan Geng, Lin Li, Jie Yan, Kevin Liu, Aizhen Yang, Lin Zhang, Yingzhi Shen, Han Gao, Xuefeng Wu, Imre Noth, Yong Huang, Junling Liu, Xuemei Fan

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: